The present invention provides novel compositions and methods for using the S-(+) enantiomer of desmethylselegiline (N-methyl-N-(prop-2-ynyl)-2-aminophenylpropane), for the treatment of selegiline-responsive diseases and conditions. Diseases and conditions responsive to selegiline include those produced...http://www.google.com.au/patents/US6319954?utm_source=gb-gplus-sharePatent US6319954 - S-(+)-desmethylselegiline and its use in the therapeutic methods and pharmaceutical compositions
